Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Secondary peritonitis epidemiology and demographics
Introduction
Overview
Overview
Despite the recent advances in treatment modalities, morbidity and mortality rates caused by peritonitis remain high.
Epidemiology and Demographics
Epidemiology and Demographics
Incidence
- The incidence of secondary peritonitis can not be measured accurately as it occurs in the context of a wide spectrum of diseases and conditions.
- At one study, the incidence of diffuse postoperative peritonitis was 25% in the surgical ICU especially in patients with multi-organ failure.[1]
Case Fatality Rate
- Morbidity and mortality of patient with secondary peritonitis is ~30%.[2][3].
- Despite the development of antibiotics and significant improvement in intensive care support, morbidity is high and mortality rates remain between 30-66%.
Age
- The mean age of perforation peritonitis is more than 60 years.
References
References
- ↑ Krastev N, Djurkov V, Murdjeva M, Akrabova P, Karparova T, Penkov V, Kiprin G, Asenov K, Krastev N, Djurkov V, Murdjeva M, Akrabova P, Karparova T, Penkov V, Kiprin G, Asenov K (2013). “Diagnosis of spontaneous and secondary bacterial peritonitis in patients with hepatic cirrhosis and ascites”. Khirurgiia (Sofiia) (in Bulgarian) (3): 20–5. PMID 24459763.
- ↑ Christou NV, Barie PS, Dellinger EP, Waymack JP, Stone HH (1993). “Surgical Infection Society intra-abdominal infection study. Prospective evaluation of management techniques and outcome”. Arch Surg. 128 (2): 193–8, discussion 198-9. PMID 8431120.
- ↑ Wacha H, Hau T, Dittmer R, Ohmann C (1999). “Risk factors associated with intraabdominal infections: a prospective multicenter study. Peritonitis Study Group”. Langenbecks Arch Surg. 384 (1): 24–32. PMID 10367626.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivani Chaparala M.B.B.S [2]